广誉远(600771) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue decreased by 16.39% to CNY 854,159,310.90 year-on-year[11] - Net profit attributable to shareholders decreased by 23.09% to CNY 173,805,818.31 compared to the same period last year[11] - Net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 30.38% to CNY 155,705,387.55[14] - Basic and diluted earnings per share decreased by 45.31% to CNY 0.35[11] - Operating profit for Q3 2019 was CNY 70,864,647.77, a decline of 30.1% from CNY 101,349,416.29 in Q3 2018[63] - Net loss for the first three quarters of 2019 reached CNY 571,602,603.13, compared to a loss of CNY 557,912,860.98 in the same period of 2018[58] - Total revenue for Q3 2019 was CNY 4,148,209.76, a decrease from CNY 4,612,104.35 in Q3 2018, representing a decline of approximately 10.06%[71] - Net profit for Q3 2019 was CNY -3,122,185.95, compared to a net profit of CNY 74,392,953.25 in Q3 2018, indicating a significant loss[71] - Total comprehensive income for Q3 2019 was CNY -3,122,185.95, compared to CNY 74,392,953.25 in Q3 2018, showing a drastic change in financial performance[74] Assets and Liabilities - Total assets increased by 10.75% to CNY 3,409,906,074.32 compared to the end of the previous year[11] - The company's total assets at the end of the reporting period were CNY 3,409,906,074.32, up from CNY 3,078,858,116.98 at the end of the previous year[11] - Total liabilities increased to CNY 891,622,863.65, up from CNY 722,676,706.84, marking a rise of 23.4%[45] - The company's equity attributable to shareholders rose to CNY 2,430,381,064.11, an increase of 6.2% from CNY 2,287,570,596.66[48] - Total current assets amounted to CNY 2,501,770,952.67, an increase of 15.1% from CNY 2,172,881,692.84 on December 31, 2018[39] - Total non-current assets were CNY 905,976,424.14 as of December 31, 2018[97] Cash Flow - Net cash flow from operating activities improved by CNY 141,229,292, primarily due to higher cash receipts from sales[29] - Financing activities generated a net cash inflow of CNY 207,040,392.92, a 232.37% increase compared to the previous year[29] - The net cash flow from operating activities for the first three quarters of 2019 was approximately -¥129 million, an improvement from -¥270 million in the same period of 2018, indicating a reduction in cash outflow by 52.2%[79] - The cash inflow from financing activities in the first three quarters of 2019 was approximately ¥379 million, compared to ¥322 million in the same period of 2018, reflecting an increase of 17.7%[82] Expenses - Research and development expenses increased by 16.33% compared to the same period last year[14] - Financial expenses increased by 187.18% year-on-year due to expanded financing channels[14] - Operating expenses increased by 301.27% to CNY 3,586,393.00, primarily due to donations made to health foundations[31] - The company reported a decrease in sales expenses to CNY 128,117,618.46 in Q3 2019 from CNY 151,738,934.33 in Q3 2018, reflecting cost control measures[63] Shareholder Information - The number of shareholders at the end of the reporting period was 29,438[18] - The company's paid-in capital increased by 39.42% to CNY 491,999,697.00, due to a capital reserve conversion into share capital[26] - Unappropriated profits rose by 114.79% to CNY 325,223,365.09, attributed to increased net profit during the reporting period[26] Inventory and Receivables - Inventory increased by 30.93% to CNY 488,839,339.09, as the company procured more raw materials in response to market conditions[25] - Other receivables rose by 143.69% to CNY 163,822,839.61, driven by enhanced market operations and increased cash payments to various regions[25] - Accounts receivable increased to CNY 1,472,751,429.59, up from CNY 1,338,389,801.06, reflecting a growth of 10%[39]